Hamostaseologie 2016; 36(S 02): S25-S28
DOI: 10.5482/HAMO-15-05-0017
Original article
Schattauer GmbH

Mutational spectrum and deep intronic variants in the factor VIII gene of haemophilia A patients

Identification by next generation sequencingMutationsspektrum und tiefe intronische Varianten im Faktor-VIII-Gen von Hämophilie-A-PatientenIdentifikation mittels Next-Generation-Sequenzierung
J. E. Bach
1   Department of Human Genetics, University of Würzburg, Germany
,
J. Oldenburg
2   Institute of Experimental Haematology and Transfusion Medicine, University of Bonn, Germany
,
C. R. Müller
1   Department of Human Genetics, University of Würzburg, Germany
,
S. Rost
1   Department of Human Genetics, University of Würzburg, Germany
› Author Affiliations
Further Information

Publication History

received: 12 May 2015

accepted in revised form: 27 November 2015

Publication Date:
30 December 2017 (online)

Summary

Haemophilia A (HA) is caused by a broad spectrum of different mutation types in the factor VIII gene (F8). In our patient cohort of more than 2600 HA patients as well as in other published studies, the most frequent cause are missense mutations in different F8 exons or the recurrent intron 22 inversion. Some exons and several specific nucleotide positions represent hot spots for point mutations in the examined cohort. About 4 % of cases remain without mutation after routine HA diagnostic methods including inversion PCRs, Sanger sequencing and multiplex ligation-dependent probe amplification (MLPA). Deep intronic mutations cannot be detected by current standard HA diagnostics but have been reported for several genetic disorders. However, next generation sequencing (NGS) of the whole genomic sequence of the F8 gene allows to identify deep intronic variants. Conclusion: In general, NGS provides an effective approach to screen for different HA causing mutation types in the F8 gene.

Zusammenfassung

Hämophilie A (HA) wird durch ein breites Spektrum verschiedener Mutationstypen im Faktor-VIII-Gen (F8) verursacht. In unserem Patientenkollektiv von über 2600 HA-Patienten und in anderen veröffentlichten Studien sind Missense-Mutationen in verschiedenen F8-Exons sowie die rekurrente Intron-22-Inversion die häufigsten Ursachen der HA. Einige Exons und bestimmte Nukleotid-Positionen stellen Hot-Spots für Punktmutationen in der untersuchten Kohorte dar. Etwa 4% der Fälle bleiben jedoch ungelöst nach Durchfüh-rung der Routine-Diagnostik, die die Inversions-PCRs, Sanger-Sequenzierung und MLPA (Multiplex Ligation-Dependent Probe Amplification) beinhaltet. Tiefe intronische Mutationen können im Rahmen der gegenwärtigen Routine-Diagnostik nicht entdeckt werden, wurden jedoch im Zusammenhang mit verschiedenen genetisch bedingten Erkrankungen berichtet. Im Rahmen der Analyse der kompletten genomischen Sequenz des F8-Gens mittels NGS (Next Generation Sequencing) können solche tiefen intronischen Varianten identifiziert werden. Schlussfolgerung: Generell stellt NGS einen effektiven Ansatz dar, das F8-Gen auf verschiedene HA verursachende Mutationstypen hin zu untersuchen.

 
  • References

  • 1 Graw J, Brackmann HH, Oldenburg J. et al. Haemophilia A: from mutation analysis to new therapies. Nat Rev Genet 2005; 6: 488-501.
  • 2 Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet. 2003; 361: 1801-1809.
  • 3 Naylor JA, Green PM, Rizza CR, Giannelli F. Analysis of factor VIII mRNA reveals defects in everyone of 28 haemophilia A patients. Hum Mol Genet 1993; 2: 11-17.
  • 4 Lakich D, Kazazian Jr HH, Antonarakis SE, Gitschier J. Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nat Genet 1993; 5: 236-241.
  • 5 Liu Q, Nozari G, Sommer SS. Single-tube polymerase chain reaction for rapid diagnosis of the inversion hotspot of mutation in hemophilia A. Blood 1998; 92: 1458-1459.
  • 6 Rossetti LC, Radic CP, Larripa IB, De Brasi CD. Genotyping the hemophilia inversion hotspot by use of inverse PCR. Clin Chem 2005; 51: 1154-1158.
  • 7 Bagnall RD, Waseem N, Green PM, Giannelli F. Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe hemophilia A. Blood 2002; 99: 168-174.
  • 8 Higuchi M, Antonarakis SE, Kasch L. et al. Molecular characterization of mild-to-moderate hemophilia A. Proc Natl Acad Sci USA 1991; 88: 8307-8311.
  • 9 Rost S, Loffler S, Pavlova A. et al. Detection of large duplications within the factor VIII gene by MLPA. J Thromb Haemost 2008; 6: 1996-1999.
  • 10 Zimmermann MA, Gehrig A, Oldenburg J. et al. Analysis of F8 mRNA in haemophilia A patients with silent mutations or presumptive splice site mutations. Haemophilia 2013; 19: 310-317.
  • 11 Metzker ML. Sequencing technologies – the next generation. Nat Rev Genet 2010; 11: 31-46.
  • 12 Pezeshkpoor B, Zimmer N, Marquardt N. et al. Deep intronic ’mutations’ cause hemophilia A. J Thromb Haemost 2013; 11: 1679-1687.
  • 13 Margaglione M, Castaman G, Morfini M. et al. The Italian AICE-Genetics hemophilia A database. Haematologica. 2008; 93: 722-728.
  • 14 Zimmermann MA, Oldenburg J, Muller CR, Rost S. Unusual genomic rearrangements in introns 1 and 22 of the F8 gene. Hämostaseologie 2011; 31 (Suppl. 01) S69-S73.
  • 15 Zimmermann MA, Oldenburg J, Muller CR, Rost S. Characterization of duplication breakpoints in the factor VIII gene. J Thromb Haemost 2010; 8: 2696-2704.
  • 16 Zimmermann MA, Meier D, Oldenburg J. et al. Identification and characterization of mutations in the promoter region of the factor VIII gene. J Thromb Haemost 2012; 10: 314-317.
  • 17 Oldenburg J, El-Maarri O. New insight into the molecular basis of hemophilia A. Int J Hematol 2006; 83: 96-102.
  • 18 Young M, Inaba H, Hoyer LW. et al. Partial correction of a severe molecular defect in hemophilia A, because of errors during expression of the factor VIII gene. Am J Hum Genet 1997; 60: 565-573.
  • 19 Tavassoli K, Eigel A, Wilke K. et al. Molecular diagnostics of 15 hemophilia A patients. Hum Mutat. 1998; 12: 301-303.
  • 20 El-Maarri O, Herbiniaux U, Graw J. et al. Analysis of mRNA in hemophilia A patients with undetectable mutations reveals normal splicing in the factor VIII gene. J Thromb Haemost 2005; 3: 332-339.
  • 21 Youssoufian H, Kazazian Jr HH, Patel A. et al. Mild hemophilia A associated with a cryptic donor splice site mutation in intron 4 of the factor VIII gene. Genomics 1988; 2: 32-36.
  • 22 Bagnall RD, Waseem NH, Green PM. et al. Creation of a novel donor splice site in intron 1 of the factor VIII gene leads to activation of a 191 bp cryptic exon in two haemophilia A patients. Br J Haematol 1999; 107: 766-771.
  • 23 Castaman G, Giacomelli SH, Mancuso ME. et al. Deep intronic variations may cause mild hemophilia A. J Thromb Haemost 2011; 9: 1541-1548.
  • 24 Inaba H, Koyama T, Shinozawa K. et al. Identification and characterization of an adenine to guanine transition within intron 10 of the factor VIII gene as a causative mutation in a patient with mild haemophilia A. Haemophilia 2013; 19: 100-105.
  • 25 Bach JE, Wolf B, Oldenburg J. et al. Identification of deep intronic variants in 15 haemophilia A patients by next generation sequencing of the whole factor VIII gene. Thromb Haemost 2015; 114.
  • 26 Santacroce R, Santoro R, Sessa F. et al. Screening of mutations of hemophilia A in 40 Italian patients. Blood Coagul Fibrinolysis 2008; 19: 197-202.
  • 27 Kircher M, Witten DM, Jain P. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 2014; 46: 310-315.